Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September ↗
Via The Motley Fool
Tickers CRSP VKTX
Exposures Product Safety
News headline image
Creative Biolabs Expands IND-Enabling Live Biotherapeutic Product Safety Assessment Capabilities
Via Get News
Exposures Product Safety
News headline image
Why Researchers Trust Premier Aminos for High-Quality Peptides
Via BusinesNews Wire
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Before the First Stroke: Why the Consultation Is Where Permanent Makeup Results Are Actually Made
Via Get News
Exposures Product Safety
News headline image
Katie Nielsen Reflects on Why Every Courtroom Experience Should Make an Attorney Better
Via Get News
Topics Product Recall
Exposures Legal Product Safety
News headline image
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) is September 28, 2026
Via NewMediaWire
Topics Fraud Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
The Peptide Research Sector Is Quietly Becoming One of Canada’s Fastest-Growing Biotech Segments
Via AB Newswire
Topics Economy Supply Chain
Exposures Product Safety Supply Chain
News headline image
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before Lead Plaintiff Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You? ↗
Via The Motley Fool
Tickers MDGL NVO
Exposures Product Safety
SS Innovations International Inc. (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm to Learn About Their Legal Rights
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
News headline image
FDA Pauses New Enrollment for Biohaven Epilepsy Drug Program ↗
Via Benzinga
Exposures Product Safety
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Via Investor Brand Network
Tickers BMY CSE:QNTM MRK NVS QNTM TGTX
Exposures Product Safety
News headline image
Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Via Investor Brand Network
Tickers BMY MRK NVS QNTM TGTX
Exposures Product Safety
News headline image
Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP ↗
Via MarketBeat
Tickers INO PLTR
Exposures Product Safety
News headline image
3 Quality Compounders with Impressive Fundamentals
Via StockStory
Tickers ATI DXCM META
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Neurotoxin TrenibotE; Spokane dermatologist Dr. Philip Werschler on What the Letter Means ↗
Via Talk Markets
Exposures Product Safety
News headline image
What Running Dozens of Simultaneous Clinical Trials Revealed About How Medicine Actually Gets Made: Dr. Phil Werschler on the Research Behind the Results ↗
Via Talk Markets
Exposures Product Safety
News headline image
Nova Warranty Addresses Coverage Gaps for Mercedes-Benz Owners Following Largest Recall Year
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Gene Therapy at Lower Dose Shows Vision Improvements, Opus Genetics Says ↗
Via Benzinga
Exposures Product Safety
News headline image
Kaplan Fox Alerts Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to an Ongoing Investigation Into Possible Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial
Via Investor Brand Network
Tickers QNTM
Exposures Product Safety
News headline image
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market ↗
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.